Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung volume reduction surgery for emphysema

E W Russi1, U Stammberger, W Weder

  • 1Dept of Internal Medicine, University Hospital, Zurich, Switzerland.

The European Respiratory Journal
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smoking prevention intervention with school classes in university hospital by thoracic surgeon und pulmonologist. The Zurich prevention project.

Preventive medicine reports·2022
Same author

Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455].

ESMO open·2022
Same author

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials.

ESMO open·2022
Same author

Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients.

EJNMMI research·2020
Same author

Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug.

Lung cancer (Amsterdam, Netherlands)·2020
Same journal

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
Same journal

ERS Statement on ultrasound guided interventions in respiratory disease.

The European respiratory journal·2026
Same journal

When symptoms and resting tests disagree in interstitial lung disease: a selective role for cardiopulmonary exercise testing.

The European respiratory journal·2026
Same journal

Clinical Practice Guideline for the diagnosis of Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) in patients with Common Variable Immunodeficiency Disorders (CVID) - an ERS Clinical Research Collaboration.

The European respiratory journal·2026
Same journal

SARS-CoV-2 (E)-protein induces rapid TLR2-mediated T cell activation in mouse lungs revealed by intravital lung microscopy.

The European respiratory journal·2026
Same journal

Functional characterization of <b><i>KCNA5</i></b> gene variants linked to pulmonary arterial hypertension.

The European respiratory journal·2026
See all related articles

Lung volume reduction surgery (LVRS) improves pulmonary function and quality of life for severe emphysema patients. This surgical intervention reduces lung hyperinflation, enhancing mechanics and expiratory flow rates.

Area of Science:

  • Pulmonary Medicine
  • Thoracic Surgery
  • Respiratory Physiology

Background:

  • Severe pulmonary emphysema causes debilitating dyspnea, impairing daily activities and quality of life.
  • Lung volume reduction surgery (LVRS) is a therapeutic option for selected patients.

Purpose of the Study:

  • To evaluate the functional improvements and outcomes of LVRS in patients with severe pulmonary emphysema.

Main Methods:

  • LVRS involves the resection of destroyed lung areas.
  • Surgical approaches include median sternotomy and video-assisted thoracoscopy (VAT) for bilateral resections.
  • Patient selection, surgical techniques, and perioperative management are critical for outcomes.

Main Results:

Related Experiment Videos

  • LVRS can reduce lung hyperinflation, improve diaphragm and chest wall mechanics, and increase elastic recoil pressure.
  • Average increases in forced expiratory volume in one second (FEV1) range from 32-93% after bilateral resection.
  • Reductions in total lung capacity (hyperinflation) range from 15-20%, with benefits lasting at least one year.

    • Conclusions:

    • LVRS offers significant functional improvements for carefully selected patients with severe emphysema.
    • The procedure enhances pulmonary function, daily activity performance, and quality of life.
    • Low perioperative mortality (<5%) is achievable with experienced teams and meticulous management.